CN202256305U - Intelligent numerical-control tester for dissolution rate of bionic medicines - Google Patents
Intelligent numerical-control tester for dissolution rate of bionic medicines Download PDFInfo
- Publication number
- CN202256305U CN202256305U CN201120271044XU CN201120271044U CN202256305U CN 202256305 U CN202256305 U CN 202256305U CN 201120271044X U CN201120271044X U CN 201120271044XU CN 201120271044 U CN201120271044 U CN 201120271044U CN 202256305 U CN202256305 U CN 202256305U
- Authority
- CN
- China
- Prior art keywords
- bionical
- gear
- stomach
- way pipe
- interface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
Images
Abstract
The utility model relates to the technical field of medicine inspection equipment and particularly relates to an intelligent numerical-control tester for a dissolution rate of bionic medicines. The intelligent numerical-control tester comprises a gastrointestinal bionic device, a sample feeding groove and a controller, wherein the gastrointestinal bionic device comprises a bionic stomach, a bionic intestinal tract communicated with the bionic stomach, a peristaltic pump and an extruding gear; the peristaltic pump and the extruding gear are abutted against the outer surface of the bionic stomach and the outer surface of the bionic intestinal tract. According to the utility model, a gastrointestinal bionic design is carried out in vitro to simulate peristalsis and digestive absorption processes of the stomach and the intestinal tract of a human body; and the intelligent numerical-control tester provided by the utility model has the advantages of high automation degree, good repeatability of detection results, good in-vitro relativity and capability of better predicating the dissolution rate of the medicines in vivo.
Description
Technical field
The utility model relates to the drug abuse test equipment technical field, and the bionical drug dissolution analyzer of particularly a kind of intelligent numerical control is applicable to dissolution rate detection, the new drug development of medicine and sets up research of inside and outside correlativity etc.
Background technology
Drug dissolution directly influences medicine absorption in vivo and utilization, is an important inherent index estimating drug quality, all need investigate this index at aspects such as check drug manufacture, clinical efficacy, stability of drug products.
The detecting instrument of drug dissolution; Begin most that main armrest is moving to extract soup from digestion instrument, after the filtration, detect with analytical approachs such as ultraviolet spectrophotometry, HPLC; The method automaticity that this manual sampling detects is not high; There is time-consuming, effort in more, the complex operation of manual steps, measures shortcomings such as hysteresiss, inconvenient operation, makes that reappearance, the homogeneity of drug dissolution detection are relatively poor.
For addressing the above problem; Chinese invention patent application (application number: 200310110015.5) disclose a kind of " the dissolution rate detector that is used for the METHOD FOR CONTINUOUS DETERMINATION multicomponent pharmaceutical "; Its technical scheme comprises sample drawing-in system, light path system, spectral detection system, the department of computer science round bottom beaker of unifying; The sample drawing-in system is made up of stopple coupon, peristaltic pump, stepper motor, and stopple coupon inserts in the round bottom beaker and with peristaltic pump and links to each other, and peristaltic pump is connected with six passage flow cells; There is light path system six passage flow cell both sides, make each passage two ends of six passage flow cells can pass through light path system successively to realize the automatic detection of drug dissolution through computer system.
Promptly develop the drug dissolution automatic analyzer abroad since the seventies in 20th century; Reached at present the stage of comparative maturity, it has experienced " medicament dissolution instrument+peristaltic pump+detecting device (ultraviolet spectrophotometer or high performance liquid chromatograph) ", " medicament dissolution instrument+UV fiber sensor+ultraviolet spectrophotometer or diode array fiber spectrometer " reaches " medicament dissolution instrument+polynary quencher fibre optic chemical sensor+diode array fiber spectrometer " three phases.Adopt optical fiber technology, CCD technology, computer technology, the incorporate combination of infotech, but the dedicated computer software automatic data acquisition and processing of medicament dissolution instrument, extract dissolution parameters, the demonstration stripping curve.
Yet; The drug dissolution automatic analyzer of prior art all constantly improves on the detection technique of drug dissolution, still, to medicament dissolution instrument in simulation to the process in leaching of external medicine; Then be simply through medicine being put into the container (like the dissolution rate cup) that dissolution medium is housed; Adopt slurry method or commentaries on classics blue laws to stir then, the experiment liquid pump in the container is gone into to carry out analyzing and testing in the detecting instrument through peristaltic pump, thus the process in leaching of replacement drug disposition.Thus; This medicament dissolution instrument can not be simulated the GI wriggling in the human body well and digested and assimilated process; The inside and outside correlativity of the feasible drug dissolution that is detected is poor; Can not predict the dissolution rate in the medicine body well, cause the testing result of external drug dissolution to have error, can not reflect medicine absorption in vivo and utilization truly.
Therefore, how designing and make a kind of analyzer that can be good at the dissolution velocity of medicine in human body, is a present stage important topic requiring study of medical circle.
To above-mentioned deficiency of the prior art; Need badly and on the basis of existing drug dissolution analyzer, carry out Bionic Design; A kind of process that can simulate the human body gastrointestinal motility and digest and assimilate is provided; Automaticity height, testing result favorable reproducibility, the drug dissolution analyzer that the inside and outside correlativity is good can be predicted medicine dissolution rate in vivo better.
Summary of the invention
The purpose of the utility model is to avoid weak point of the prior art, and a kind of automaticity height, testing result favorable reproducibility, drug dissolution analyzer that the inside and outside correlativity is good are provided.
The purpose of the utility model realizes through following technical measures:
The utility model provides a kind of intelligent numerical control bionical drug dissolution analyzer; Include stomach and intestine bionic device, loading slot and controller; The stomach and intestine bionic device is provided with application of sample mouth and sample tap; Loading slot offers through hole, and through hole is communicated with the application of sample mouth through first silicone tube, and sample tap is communicated with second silicone tube;
Said stomach and intestine bionic device includes bionical stomach, the bionical enteron aisle that is communicated with bionical stomach, peristaltic pump and extruding gear; The outside surface of peristaltic pump, extruding gear and the outside surface of bionical stomach, bionical enteron aisle is inconsistent; The transmission shaft of the transmission shaft of peristaltic pump, extruding gear is connected with direct current generator respectively, and direct current generator is connected with controller.
Wherein, Loading slot includes first loading slot, second loading slot; The application of sample mouth includes the first application of sample mouth, the second application of sample mouth, and the first application of sample mouth is arranged at the medicine input end of bionical stomach, and the first application of sample mouth is communicated with first loading slot through first silicone tube; The second application of sample mouth is arranged at bionical enteron aisle, and the second application of sample mouth is communicated with second loading slot through first silicone tube.
Wherein, the second application of sample mouth is provided with first three-way pipe, and first interface, second interface of first three-way pipe are communicated with bionical enteron aisle respectively, and the 3rd interface of first three-way pipe is connected with second loading slot through first silicone tube.
Wherein, sample tap includes first sample tap, second sample tap, and first sample tap is arranged at the junction of bionical stomach and bionical enteron aisle, and second sample tap is arranged at bionical enteron aisle.
Wherein, first sample tap is provided with second three-way pipe, and first interface of second three-way pipe is communicated with bionical stomach, and second interface of second three-way pipe is communicated with bionical enteron aisle, and the 3rd interface of second three-way pipe is connected with second silicone tube; Second sample tap is provided with the 3rd three-way pipe, and first interface of the 3rd three-way pipe, second interface are communicated with bionical enteron aisle, and the 3rd interface of the 3rd three-way pipe is connected with second silicone tube.
Wherein, the 3rd interface of first three-way pipe, the 3rd interface of second three-way pipe, the 3rd three-way pipe the 3rd interface are respectively arranged with operation valve, and operation valve is connected with stepper motor, and stepper motor is connected with controller.
Wherein, Peristaltic pump includes transmission shaft, gear fixed head, first gear that is connected with the gear fixed head, second gear, the 3rd gear; Transmission shaft is connected with direct current generator; Driving sleeve is provided with transmission gear, transmission gear respectively with first gear, second gear, the 3rd gearing mesh, the axle center of first gear, second gear, the 3rd gear is triangular arranged.
Wherein, the number of teeth of said extruding gear, first gear, second gear, the 3rd gear is set to 40～50, and the tooth top of said extruding gear, first gear, second gear, the 3rd gear is a plane, and the width of said tooth top is at least 0.3cm.
Wherein, said stomach and intestine bionic device, loading slot are respectively arranged with constant water bath box.
Wherein, the bionical drug dissolution analyzer of intelligent numerical control also includes liquid waste treating apparatus, and the waste liquid input end of said liquid waste treating apparatus is connected with the soup output terminal of said bionical enteron aisle.
The beneficial effect of the utility model:
The bionical drug dissolution analyzer of the intelligent numerical control of the utility model; Include stomach and intestine bionic device, loading slot and controller; The stomach and intestine bionic device is provided with application of sample mouth and sample tap; Loading slot offers through hole, and through hole is communicated with the application of sample mouth through first silicone tube, and sample tap is communicated with second silicone tube; The stomach and intestine bionic device includes bionical stomach, the bionical enteron aisle that is communicated with bionical stomach, peristaltic pump and extruding gear; The outside surface of peristaltic pump, extruding gear and the outside surface of bionical stomach, bionical enteron aisle is inconsistent; The transmission shaft of the transmission shaft of peristaltic pump, extruding gear is connected with direct current generator respectively, and direct current generator is connected with controller.The stomach and intestine bionic device of the utility model is architectural feature, physiological environment and the forms of motion thereof according to the human intestines and stomach; In the external Bionic Design of carrying out; Peristaltic pump is wriggled and is rolled at bionical stomach, bionical enteron aisle outside surface with the extruding gear, through the speed of DC MOTOR CONTROL peristaltic pump with the extruding gear, has simulated the characteristics that the human body stomach digests and absorbs with the mode of motion of wriggling; Thereby reflected medicine process in leaching in vivo truly, the inside and outside correlativity is good.Controller can be realized adding solution, testing from the sample tap sampling from the application of sample mouth automatically according to the predefined time, and automaticity is high, has reduced loaded down with trivial details manually-operated, reappearance, good uniformity that external drug dissolution detects.
Description of drawings
Utilize accompanying drawing that the utility model is further specified, but the content in the accompanying drawing does not constitute any restriction to the utility model.
Fig. 1 is the structural representation of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 2 is the simulating sports synoptic diagram of bionical stomach of stomach and intestine bionic device of the embodiment 1 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 3 is the simulating sports synoptic diagram of bionical enteron aisle of stomach and intestine bionic device of the embodiment 1 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 4 is the structural representation of loading slot of the embodiment 1 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 5 is the structural representation of first three-way pipe of the embodiment 1 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 6 is the structural representation of peristaltic pump of the embodiment 2 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 7 is the first gear structure synoptic diagram of peristaltic pump of the embodiment 2 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
Fig. 8 is the structural representation of extruding gear of the embodiment 2 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model.
In Fig. 1 to Fig. 8, include:
Stomach and intestine bionic device 1, bionical stomach 11, bionical enteron aisle 12, extruding gear 14;
Peristaltic pump 13, first gear 131, second gear 132, the 3rd gear 133, gear fixed head 134, transmission shaft 135, transmission gear 136;
Loading slot 2, first loading slot 21, second loading slot 22, through hole 23;
First three-way pipe 6, second three-way pipe 7, the 3rd three-way pipe 8;
Liquid waste treating apparatus 9.
Embodiment
In conjunction with following examples the utility model is further described:
Embodiment 1
The embodiment 1 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model is extremely shown in Figure 5 like Fig. 1; Include stomach and intestine bionic device 1, loading slot 2 and controller 3; Stomach and intestine bionic device 1 is provided with application of sample mouth and sample tap; Loading slot 2 offers through hole 23, and through hole 23 is communicated with the application of sample mouth through first silicone tube 4, and sample tap is communicated with second silicone tube 5; Stomach and intestine bionic device 1 includes bionical stomach 11, the bionical enteron aisle 12 that is communicated with bionical stomach 11, peristaltic pump 13 and extruding gear 14; The outside surface of peristaltic pump 13, the outside surface that pushes gear 14 and bionical stomach 11, bionical enteron aisle 12 is inconsistent; The transmission shaft of the transmission shaft of peristaltic pump 13, extruding gear 14 is connected with direct current generator respectively, and direct current generator is connected with controller 3.
Loading slot 2 includes first loading slot 21, second loading slot 22, and the application of sample mouth includes the first application of sample mouth, the second application of sample mouth, and the first application of sample mouth is arranged at the medicine input end of bionical stomach 11, and the first application of sample mouth is communicated with first loading slot 21 through first silicone tube 4.The second application of sample mouth is arranged at bionical enteron aisle 12, the second application of sample mouths and is communicated with second loading slot 22 through first silicone tube 4.
Concrete, first loading slot is equipped with experimental liquid, and this experimental liquid is the solution of physiological environments such as simulation human body gastrointestinal contents;
Concrete, second loading slot is equipped with blank liquid, and this blank liquid is the liquid of required additional equivalent of taking out from sample tap.
First interface, second interface that the second application of sample mouth is provided with first three-way pipe, 6, the first three-way pipes 6 are communicated with bionical enteron aisle 12 respectively, and the 3rd interface of first three-way pipe 6 is connected with second loading slot 22 through first silicone tube 4.
Preferably, sample tap includes first sample tap, second sample tap, and first sample tap is arranged at the junction of bionical stomach 11 and bionical enteron aisle 12, and second sample tap is arranged at bionical enteron aisle 12.
First interface that first sample tap is provided with second three-way pipe, 7, the second three-way pipes 7 is communicated with bionical stomach 11, and second interface of second three-way pipe is communicated with bionical enteron aisle 12, and the 3rd interface of second three-way pipe is connected with second silicone tube 5;
First interface, second interface that second sample tap is provided with the 3rd three-way pipe 8, the three three-way pipes 8 are communicated with bionical enteron aisle 12, and the 3rd interface of the 3rd three-way pipe is connected with second silicone tube 5.
Preferred, the 3rd interface of the 3rd interface of first three-way pipe 6, second three-way pipe 7, the 3rd interface of the 3rd three-way pipe 8 are respectively arranged with operation valve, and operation valve is connected with stepper motor, and stepper motor is connected with controller 3.Sample time can be preestablished; Precisely turning to of operation valve through the step motor control three-way pipe, when operation valve was opened, the 3rd interface of second three-way pipe, the 3rd interface of the 3rd three-way pipe were communicated with second silicone tube 5; Soup flows out from second silicone tube 5 automatically; Can connect a container containing at the output terminal of second silicone tube 5, can realize the automatic sampling of soup, carry out the detection of external drug dissolution then.
In the present embodiment; Bionical stomach 11, bionical intestines 12 roads are processed by silica gel material, because soft, high temperature resistant, the acid-alkali-corrosive-resisting of silica gel, therefore; Bionical stomach 11, bionical enteron aisle 12 are selected this material of silica gel for use, and the physiological environment of in-vitro simulated stomach and intestine is had good tolerance.
Bionical enteron aisle 12 is a straight silicone tube; Because the small intestine diameter of human body is 4cm; The large intestine diameter is 6cm, and the length of small intestine and large intestine is longer, therefore; Bionical enteron aisle 12 is designed to a straight silicone tube with large intestine and small intestine, and the diameter of this silicone tube and length are carried out a certain proportion of dwindling according to the large intestine of human body, the diameter and the length of small intestine.
The internal diameter of first silicone tube 4, second silicone tube 5 is 2cm, and external diameter is 2.5cm, because the diameter of tablet generally is no more than 1cm, when guaranteeing the silicone tube motion, medicine can pass through, and selects the silicone tube of internal diameter greater than the tablet diameter.
In the present embodiment; As embodiment preferred; Stomach and intestine bionic device 1, loading slot 2 are respectively arranged with constant water bath box, owing to have uniform temperature in the human intestines and stomach, the purpose that adopts constant water bath box is the temperature that makes stomach and intestine physiological environment in external stomach and intestine bionic device 1 analogue body.
The stomach and intestine bionic device 1 of the utility model is architectural feature, physiological environment and the forms of motion thereof according to the human intestines and stomach, and the movement characteristic of physiological environment through in-vitro simulated stomach, small intestine, large intestine and stomach, small intestine, large intestine carries out Bionic Design to stomach and intestine:
The physiological environment of 1 simulated gastric, small intestine, large intestine (content)
1.1 gastric juice
Gastric juice is colourless acidic liquid, and pH is 0.9～1.5, and normal person's secretory volume every day is 1.5～2.5L.Normal person's salt acid output on an empty stomach is 0～5mmol/L.Under the situation of food or medicine irritation, can reach 20～25mmol/L.Propepsin is divided into two kinds on I type and II type, and two kinds function is identical.The mucus that the gastric mucosal cell secretion is two types.Mucobicarbonate barrier is the protection stomach lining, but because our stomach bag acid and alkali-resistance need not protect, so can not add.Intrinsic factor is a kind of glycoprotein, and molecular weight is 55000, promotes that the cobalamin in the food absorbs.And trace element has Fe, Cu, Zn, Ni, Mo in the stomach.
1.2 small intestine
1.2.1 bile
Liver cell continues to generate and secretion of bile, and at interdigestive phase, bile gets into gall-bladder through cystic duct and also stored, and enters duodenum again in the period of digestion.Normal adult secretion of bile every day 600～1200ml.Liver cell bile (hepatic bile) pH value is 7.8～8.6.Gall bladder bile: the pH value is 7.0～7.4.Its composition is that inorganics has water (97%), Na
+, K
+, Cl
-, HCO3
-; Organism has bile acid, bile pigments, phosphide, cholesterol and lecithin.Bile acid combines the sodium salt or the sylvite of formation with glycocoll, mainly be sodium salt.
1.2.2 pancreatic juice
Pancreatic juice is a kind of colourless akaline liquid, and pH is about 8.0, the about 1.5L of secretion every day.Pancreatic juice is rich in the akaline liquid of mucus and water, and composition comprises that water, inorganics and organism, organism mainly are digestive ferments, like proteolytic enzyme, diastase, lipase etc.Proteolytic enzyme in the pancreatic juice mainly contains trypsase, elk proteinase, elastoser and hydroxyl peptase etc.Under the effect of the enterokinase of trypsinogen in intestinal juice, be converted into activated trypsase.Amylopsin can be disaccharides and a small amount of trisaccharide with starch, glycogen and majority of gas carbohydrate inversion, but can not hydrocellulose.Its optimal pH is 7.The main pancreatic lipase of pancreatic lipase is a triacylglycerol ester hydolyases.It can be hydrolyzed to fatty acid, monoglyceride and glycerine with neutral fat with the activity form secretion.
1.3 large intestine
Big intestinal mucosa secreting mucus, moisture, potassium ion, sodion, supercarbonate, and lysozyme, dipeptidase and micro-diastase, but do not contain enterokinase, invertase and proteinase etc., the pH value is 8.3～8.4.Contain 0.4% mucin in the large intestine secretion.The endocrine cell of large intestine can be secreted serotonin, vasoactive intestinal peptide, P material, growth hormone release inhibiting hormone, Magainin, enteroglucagon and enkephalins etc.The kind of bacterium is a lot of in the large intestine, can reach kind more than 400, and concentration reaches 1011-1012CFU/ml (CFU: clump count).Main bacteria seed has Gram-negative anaerobism bacteroid, fusiform bacilarmature, lactobacillus, Gram-positive anaerobic spore-bearing bacilli class, multiple anaerobic cocci, and Escherichia coli, proteus, aerobacteria and some fungi etc.
The movement characteristic of 2 simulated gastric, small intestine, large intestine
2.1 the motion of stomach
The strong contraction of discontinuity can take place in tail region and epimere small intestine.Contraction starts from the middle part of body of stomach, and advances to the tail region, and is every at a distance from 90min generation 1 time, continues 3～5min at every turn, is called dividing a word with a hyphen at the end of a line property compound motion.After the feed, stomach begins tangible wriggling.Wriggling begins from the middle part of stomach, has rhythm and pace of moving things ground to advance to the pylorus direction.Therefore, normally one woe goes and another comes on whole Weishang, so we adopt the vibrations of stomach bag two ends, and middle every method motion of simulated gastric well at a distance from a few minutes extruding.
2.2 the motion of small intestine
Motion has tonic contraction, segmentation movement, wriggling, and (promoting chyme moves: 0.5～2cm/s), dividing a word with a hyphen at the end of a line property compound motion (arise from the stomach bottom, slowly divide a word with a hyphen at the end of a line to the anus direction, per 60～90min takes place 1 time)
2.3 the motion of large intestine
Motion is divided into propelling property forms of motion has wriggling, merogenesis ahead running, many bags of ahead runnings and group to advance four kinds.
Thus, the movement characteristic of stomach and intestine is the form of wriggling.
The structure of 3 simulated gastric, small intestine, large intestine
3.1 the simulation of stomach
Stomach fasting volume 50ml can reach 1.5～3L after the meal, presses in the stomach to change not quite about 5mmHg.According to reckoning, the stomach bag can be made into the about 8～10cm of diameter, and length is that the end of 13～16cm is bigger, less irregular cylindrical of an end.
3.1 the simulation of small intestine
The about 4cm of small intestine diameter, long 5～6m; The belt pleat of small intestine, fine hair, microvillus make the small intestinal mucosa surface area increase by 600 times altogether, reach 200～250m
2
3.1 the simulation of large intestine
About the long 1.5m of large intestine, the about 6cm of diameter has 2～5 rectum lobes at ampullar recti, and common 3 semilunes are walked crosswise mucosal fold; Mostly be spirality first quarter moon shape, claim rectum lobe or rectum cross wall, form jointly by mucous membrane, circular muscle and longitudinal muscle; Outstanding in the chamber, wide 0.8～1.6cm, long 1.6～5.6cm.
To sum up; The utility model adopts the movement characteristic of peristaltic pump simulated gastric, small intestine, large intestine; Through hocket extruding and discharge pumping fluid of the elasticity delivery hose to peristaltic pump; The mode that peristaltic pump pushes the surface of stomach and intestine is simulated, through the speed different motion of coming the emulation stomach and intestine of control direct current generator.
Peristaltic pump 13 and extruding gear 14 are wriggled and are rolled at the outside surface of bionical stomach 11, bionical enteron aisle 12; The characteristics that the human body stomach digests and absorbs with the mode of motion of wriggling have been simulated; Thereby reflected medicine process in leaching in vivo truly, the inside and outside correlativity is good.Controller 3 can be realized adding solution, testing from the sample tap sampling from the application of sample mouth automatically according to the predefined time, and automaticity is high, has reduced loaded down with trivial details manually-operated, reappearance, good uniformity that external drug dissolution detects.
The embodiment 2 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model is extremely shown in Figure 8 like Fig. 6; The main technical schemes of present embodiment is identical with embodiment 1; Difference is; Peristaltic pump 13 includes transmission shaft 135, gear fixed head 134, first gear 131 that is connected with gear fixed head 134, second gear 132, the 3rd gear 133, and transmission shaft 135 is connected with direct current generator, and transmission shaft 135 is arranged with transmission gear 136; Transmission gear 136 respectively with first gear 131, second gear 132,133 engagements of the 3rd gear, the axle center of first gear 131, second gear 132, the 3rd gear 133 is triangular arranged.
Preferably, the number of teeth of extruding gear 14, first gear 131, second gear 132, the 3rd gear 133 is set to 40～50.
Preferably, the tooth top of extruding gear 14, first gear 131, second gear 132, the 3rd gear 133 is a plane, and the width of tooth top is at least 0.3cm.Adopt this gear structure, can simulate the forms of motion of human body gastrointestinal peristalsis better.
The embodiment 3 of the bionical drug dissolution analyzer of the intelligent numerical control of the utility model is as shown in Figure 1; The main technical schemes of present embodiment is identical with embodiment 2; Difference is; The bionical drug dissolution analyzer of intelligent numerical control also includes liquid waste treating apparatus 9, and the waste liquid input end of liquid waste treating apparatus is connected with the soup output terminal of bionical enteron aisle 12.Owing to contain various chemical substances in the soup, directly discharge pollutes environment, therefore, adopts 9 pairs of soups of being discharged by the soup output terminal of bionical enteron aisle of liquid waste treating apparatus to handle, and has the advantage of environmental protection.
Should be noted that at last; Above embodiment only be used to explain the utility model technical scheme but not to the restriction of the utility model protection domain; Although the utility model has been done detailed description with reference to preferred embodiment; Those of ordinary skill in the art should be appreciated that and can make amendment or be equal to replacement the technical scheme of the utility model, and do not break away from the essence and the scope of the utility model technical scheme.
Claims (10)
1.
The bionical drug dissolution analyzer of a kind of intelligent numerical control; It is characterized in that: include stomach and intestine bionic device, loading slot and controller; The stomach and intestine bionic device is provided with application of sample mouth and sample tap; Loading slot offers through hole, and through hole is communicated with the application of sample mouth through first silicone tube, and sample tap is communicated with second silicone tube;
Said stomach and intestine bionic device includes bionical stomach, the bionical enteron aisle that is communicated with bionical stomach, peristaltic pump and extruding gear; The outside surface of peristaltic pump, extruding gear and the outside surface of bionical stomach, bionical enteron aisle is inconsistent; The transmission shaft of the transmission shaft of peristaltic pump, extruding gear is connected with direct current generator respectively, and direct current generator is connected with controller.
2.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 1; It is characterized in that: loading slot includes first loading slot, second loading slot; The application of sample mouth includes the first application of sample mouth, the second application of sample mouth, and the first application of sample mouth is arranged at the medicine input end of bionical stomach, and the first application of sample mouth is communicated with first loading slot through first silicone tube; The second application of sample mouth is arranged at bionical enteron aisle, and the second application of sample mouth is communicated with second loading slot through first silicone tube.
3.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 2; It is characterized in that: the second application of sample mouth is provided with first three-way pipe; First interface, second interface of first three-way pipe are communicated with bionical enteron aisle respectively, and the 3rd interface of first three-way pipe is connected with second loading slot through first silicone tube.
4.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 3, it is characterized in that: sample tap includes first sample tap, second sample tap, and first sample tap is arranged at the junction of bionical stomach and bionical enteron aisle, and second sample tap is arranged at bionical enteron aisle.
5.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 4; It is characterized in that: first sample tap is provided with second three-way pipe; First interface of second three-way pipe is communicated with bionical stomach; Second interface of second three-way pipe is communicated with bionical enteron aisle, and the 3rd interface of second three-way pipe is connected with second silicone tube; Second sample tap is provided with the 3rd three-way pipe, and first interface of the 3rd three-way pipe, second interface are communicated with bionical enteron aisle, and the 3rd interface of the 3rd three-way pipe is connected with second silicone tube.
6.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 5; It is characterized in that: the 3rd interface of first three-way pipe, the 3rd interface of second three-way pipe, the 3rd three-way pipe the 3rd interface are respectively arranged with operation valve; Operation valve is connected with stepper motor, and stepper motor is connected with controller.
7.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 1; It is characterized in that: peristaltic pump includes transmission shaft, gear fixed head, first gear that is connected with the gear fixed head, second gear, the 3rd gear; Transmission shaft is connected with direct current generator; Driving sleeve is provided with transmission gear, transmission gear respectively with first gear, second gear, the 3rd gearing mesh, the axle center of first gear, second gear, the 3rd gear is triangular arranged.
8.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 7; It is characterized in that: the number of teeth of said extruding gear, first gear, second gear, the 3rd gear is set to 40～50; The tooth top of said extruding gear, first gear, second gear, the 3rd gear is a plane, and the width of said tooth top is at least 0.3cm.
9.
According to the bionical drug dissolution analyzer of the intelligent numerical control of claim 1, the said stomach and intestine bionic device of its characteristic, loading slot are respectively arranged with constant water bath box.
10. according to the bionical drug dissolution analyzer of the intelligent numerical control of claim 1; It is characterized in that: the bionical drug dissolution analyzer of intelligent numerical control also includes liquid waste treating apparatus, and the waste liquid input end of said liquid waste treating apparatus is connected with the soup output terminal of said bionical enteron aisle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201120271044XU CN202256305U (en) | 2011-07-28 | 2011-07-28 | Intelligent numerical-control tester for dissolution rate of bionic medicines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201120271044XU CN202256305U (en) | 2011-07-28 | 2011-07-28 | Intelligent numerical-control tester for dissolution rate of bionic medicines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202256305U true CN202256305U (en) | 2012-05-30 |
Family
ID=46117526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201120271044XU Withdrawn - After Issue CN202256305U (en) | 2011-07-28 | 2011-07-28 | Intelligent numerical-control tester for dissolution rate of bionic medicines |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202256305U (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102313795A (en) * | 2011-07-28 | 2012-01-11 | 广东医学院 | Intelligent numerical control bionic drug dissolubility tester |
| CN105702146A (en) * | 2015-12-31 | 2016-06-22 | 南通东概念新材料有限公司 | Bionic dynamic mouse stomach-duodenum digestive system simulation device and simulation experiment method |
| WO2020034495A1 (en) * | 2018-08-14 | 2020-02-20 | 晓东宜健（苏州）仪器设备有限公司 | Bionic human esophagus and gastric digestive system |
| CN112094732A (en) * | 2020-10-10 | 2020-12-18 | 复旦大学附属金山医院 | Culture apparatus is collected to fungus crowd of intestinal disease inspection usefulness |
-
2011
- 2011-07-28 CN CN201120271044XU patent/CN202256305U/en not_active Withdrawn - After Issue
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102313795A (en) * | 2011-07-28 | 2012-01-11 | 广东医学院 | Intelligent numerical control bionic drug dissolubility tester |
| CN102313795B (en) * | 2011-07-28 | 2014-11-12 | 广东医学院 | Intelligent numerical control bionic drug dissolubility tester |
| CN105702146A (en) * | 2015-12-31 | 2016-06-22 | 南通东概念新材料有限公司 | Bionic dynamic mouse stomach-duodenum digestive system simulation device and simulation experiment method |
| CN105702146B (en) * | 2015-12-31 | 2018-10-19 | 陈晓东 | Bionical dynamic mouse stomach-duodenum digestive system simulator and analogue experiment method |
| WO2020034495A1 (en) * | 2018-08-14 | 2020-02-20 | 晓东宜健（苏州）仪器设备有限公司 | Bionic human esophagus and gastric digestive system |
| US11645950B2 (en) | 2018-08-14 | 2023-05-09 | Xiaodongyijian (Suzhou) Instruments And Equipment Co., Ltd. | Bionic human esophagus and gastric digestive system |
| CN112094732A (en) * | 2020-10-10 | 2020-12-18 | 复旦大学附属金山医院 | Culture apparatus is collected to fungus crowd of intestinal disease inspection usefulness |
| CN112094732B (en) * | 2020-10-10 | 2024-03-12 | 复旦大学附属金山医院 | Flora collection and cultivation device for intestinal disease examination |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102313795B (en) | Intelligent numerical control bionic drug dissolubility tester | |
| CN202256305U (en) | Intelligent numerical-control tester for dissolution rate of bionic medicines | |
| Li et al. | Current in vitro digestion systems for understanding food digestion in human upper gastrointestinal tract | |
| Mayer et al. | Brain–gut microbiome interactions and functional bowel disorders | |
| Bajaj et al. | Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo‐controlled trial | |
| Huang et al. | Perturbation of the lipid metabolism and intestinal inflammation in growing pigs with low birth weight is associated with the alterations of gut microbiota | |
| CN103926375B (en) | A kind of device and using method simulating human consumption's glycolysis system | |
| Kang et al. | Gut microbial and short-chain fatty acid profiles in adults with chronic constipation before and after treatment with lubiprostone | |
| Whyte et al. | Pathophysiology of diarrhoea | |
| Souliman et al. | Investigation of the biopharmaceutical behavior of theophylline hydrophilic matrix tablets using USP methods and an artificial digestive system | |
| Zhang et al. | Prevention of loperamide induced constipation in mice by KGM and the mechanisms of different gastrointestinal tract microbiota regulation | |
| WO2017065595A2 (en) | Automated system for simulating the human digestive tract | |
| Li et al. | Correlation between kidney function and intestinal biological characteristics of adenine and folium sennae-induced diarrhea model in mice | |
| CN207717742U (en) | A kind of simulation slaking apparatus of food allergen | |
| Nagar et al. | In vitro bioaccessibility of polyphenolic compounds: The effect of dissolved oxygen and bile | |
| Wang et al. | The capacity of the fecal microbiota from Malawian infants to ferment resistant starch | |
| Zhang et al. | Anthocyanins from opuntia ficus-indica modulate gut microbiota composition and improve short-chain fatty acid production | |
| CN110531058A (en) | A kind of the in vitro digestion reaction unit and application method of economic algae | |
| Nagai et al. | In vitro and in vivo effects of selected fibers on the pharmacokinetics of orally administered carbamazepine: Possible interaction between therapeutic drugs and semisolid enteral nutrients | |
| Xu et al. | Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro by human gut microbiota of polysaccharides from Ficus carica Linn. | |
| CN209894792U (en) | Experimental device for automatically simulating gastrointestinal continuous digestion | |
| CN102302163A (en) | Biotin natural vegetable and fruit powder and preparation method thereof | |
| CN202196058U (en) | Medicine absorber | |
| He et al. | Influence of colonic dialysis using Chinese medicine on creatinine decomposition by intestinal bacteria in uremia rats | |
| Wedenoja et al. | Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| AV01 | Patent right actively abandoned |
Granted publication date: 20120530 Effective date of abandoning: 20141112 |
|
| RGAV | Abandon patent right to avoid regrant |